Healthcare & Medical Devices Global On demand · 24-48h

Global Widely-targeted Metabolomics Market Strategic Research Report

Global Widely-targeted Metabolomics Market Strategic Researc…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Widely-targeted Metabolomics Market
$2622025
10.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Plant Widely-targeted Metabolomics, Animal Widely-targeted Metabolomics

By Application: Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Contract Research Organizations

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Creative Proteomics, Lifeasible, BGI Genomics, Metware Biotechnology Inc (Metware), TianGen, Gene Denovo, SHANGHAI OE Biotech, ShangHai Biotree

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 87 pages
Market size 2025
$262
Million USD
Forecast CAGR
10.5%
2025-2032
Forecast 2032
$527
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Widely-targeted Metabolomics market size is predicted to grow from US$ 262 million in 2025 to US$ 522 million in 2032; it is expected to grow at a CAGR of 10.5% from 2026 to 2032.

Widely targeted metabolome is a metabolome detection technology that integrates the advantages of non-targeted and targeted metabolite detection technologies.The widely targeted metabolome can compare the types and abundance differences of metabolites between different samples, screen out significant differences in metabolites with important biological significance between different groups, and qualitatively and quantitatively detect low-abundance trace-level compounds.

Global key Widely-targeted Metabolomics players cover Creative Proteomics, Lifeasible, BGI Genomics, Metware Biotechnology Inc (Metware), TianGen, etc.

This report presents a comprehensive overview of the global Widely-targeted Metabolomics market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Plant Widely-targeted Metabolomics
  • Animal Widely-targeted Metabolomics

Segment by Application

  • Academic and Research Institutions
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Widely-targeted Metabolomics market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Contract Research Organizations evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Widely-targeted Metabolomics Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 10.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$262
2025
Forecast
$527
2032
CAGR
10.5%
2025–2032
Régions
5
global
Key companies
Creative ProteomicsLifeasibleBGI GenomicsMetware Biotechnology Inc (Metware)TianGenGene DenovoSHANGHAI OE BiotechShangHai Biotree
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Plant Widely-targeted MetabolomicsAnimal Widely-targeted Metabolomics
By Application
Academic and Research InstitutionsPharmaceutical and Biotechnology CompaniesContract Research Organizations

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Plant Widely-targeted Metabolomics
  • 3.1.3 Animal Widely-targeted Metabolomics
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Academic and Research Institutions
  • 4.1.3 Pharmaceutical and Biotechnology Companies
  • 4.1.4 Contract Research Organizations
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Creative Proteomics
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Lifeasible
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 BGI Genomics
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Metware Biotechnology Inc (Metware)
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 TianGen
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Gene Denovo
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 SHANGHAI OE Biotech
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 ShangHai Biotree
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Widely-targeted Metabolomics market?
The global Widely-targeted Metabolomics market is estimated at US$ 262 million in 2025 (base year) and is projected to reach US$ 522 million by 2032.
How fast is the Widely-targeted Metabolomics market expected to grow?
The market is expected to grow at a CAGR of 10.5% from 2026 to 2032, expanding from US$ 262 million in 2025 to US$ 522 million in 2032, roughly 2.0 times its base-year value.
What does the Widely-targeted Metabolomics market cover?
Widely targeted metabolome is a metabolome detection technology that integrates the advantages of non-targeted and targeted metabolite detection technologies.The widely targeted metabolome can compare the types and abundance differences of metabolites between different samples, screen out significant differences in metabolites with important biological significance between different groups, and qualitatively and quantitatively detect low-abundance trace-level compounds.
How is the Widely-targeted Metabolomics market segmented by type?
By type, the market is segmented into Plant Widely-targeted Metabolomics and Animal Widely-targeted Metabolomics.
What are the key applications of Widely-targeted Metabolomics?
Key applications covered include Academic and Research Institutions, Pharmaceutical and Biotechnology Companies and Contract Research Organizations.
Which companies are profiled in the Widely-targeted Metabolomics market report?
Key players profiled include Creative Proteomics, Lifeasible, BGI Genomics, Metware Biotechnology Inc (Metware), TianGen, Gene Denovo, SHANGHAI OE Biotech and ShangHai Biotree.
What geographies does the Widely-targeted Metabolomics market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Widely-targeted Metabolomics market report?
The report is intended for manufacturers and solution providers, distributors and end users in Academic and Research Institutions, Pharmaceutical and Biotechnology Companies and Contract Research Organizations, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Widely-targeted Metabolomics market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.